The Indirect-Cost War: Courts Blocked the 15% Cap, So Washington Will Try the Side Door

Budget ideas in Washington often show up like a “temporary” committee: they arrive with earnest paperwork and stay like they pay rent. This week’s repeat visitor is the proposed 15% cap on research indirect costs, marketed as thrift and waved at America’s laboratories like a universal coupon.

According to an April 14 update from the Association of Public and Land-grant Universities (APLU), the deadline has passed for the administration to ask the U.S. Supreme Court to review a lower-court ruling blocking major cuts to Facilities and Administrative (F&A) reimbursements on NIH grants. APLU adds that, with that window closed and with favorable rulings in related cases, litigation challenging the attempted 15% cap across NIH, NSF, DOE, and DOD is effectively over. For now, the cap stays blocked.

What “indirect costs” actually pay for

Start with translation. Indirect costs, often called F&A, are the expenses that keep research upright: buildings, utilities, compliance staff, cybersecurity, lab safety, grant administration, animal care, and the unglamorous infrastructure that makes experiments possible and lawful. These rates are typically negotiated. The attempted policy shift was to replace that negotiated system with a one-size-fits-all 15% cap.

The Association of American Medical Colleges (AAMC), tracking the litigation, notes that the Justice Department declined to seek Supreme Court review of the First Circuit’s January 6, 2026 decision upholding the injunction that blocked NIH’s attempted 15% cap, leaving the district court’s order in place. The legal bottom line is plain: the courts kept the cap blocked and the government did not take the final shot.

The Orwell check: “overhead” is a power word

Here’s the Orwell check: what language makes control sound like common sense? In this fight, the spell word is “overhead.” It suggests fluff. It invites applause for cuts without forcing anyone to say what gets weaker: cybersecurity, compliance, safety systems, the staff who keep grants running.

Call it “streamlining” and it sounds modern. Call it “efficiency” and it sounds responsible. But a flat cap is also a way to move leverage from negotiated agreements into the hands of whoever writes the memo.

The Paine test: liberty versus leverage

The Paine test asks: does this expand liberty or concentrate power? Negotiated rates function like due process in budgeting form: disclose, negotiate, document, and live under rules that can be challenged and reviewed. A unilateral cap is a shortcut around that table. And government shortcuts have a long history of turning into permanent roadways.

The tradeoff: reform in daylight, not by ambush

APLU warns the administration is again proposing a 15% cap for NIH in its FY 2027 budget and notes OMB could pursue changes through Uniform Guidance. In other words, the method may change even if the message stays the same.

If policymakers want to overhaul indirect costs, there is a grown-up path: propose a model, put it in public view, take testimony, compare outcomes, and publish audits. APLU points to an alternative model developed by a higher education coalition, which at least invites an argument with math instead of slogans.

And institutions should meet the public halfway: if you want trust, show where indirect dollars go in plain English. Sunshine is cheaper than litigation. With this court chapter closed, the next question is simple: reform in the sunlight, or control in the shadows?